Dublin-based Medtronic has acquired Dutch diabetes clinic and research center Diabeter in a deal marking the devicemaker's first entry into healthcare management.
Data Points for the week of March 30, 2015, covered the following topics: Medicare, Medicaid, cancer, diabetes, data breaches and uncompensated care
The number of Medicaid patients diagnosed with diabetes soared in states that expanded Medicaid eligibility to low-income adults last year compared with what happened in states that did not expand their Medicaid programs.
French drugmaker Sanofi won FDA approval last week to sell its newest long-acting diabetes medication Toujeo as the company looks to repeat the success of its blockbuster insulin product Lantus.
The Food and Drug Administration has approved the first mobile medical app that will allow remote monitoring of patient glucose data. The technology, from medical-device firm Dexcom, was approved through the so-called “de novo” pathway.
Salt intake was not associated with an increased risk of mortality or cardiovascular disease and health failure among older adults, according to a study published Monday.
Data Points for the week of Jan. 19, 2015, covered the following topics: Unexpected medical expenses, Medicaid, diabetes, uninsured adults, alcohol poisoning
The value of sustained initiatives targeting population health appears borne out by a dip in hospitalization and mortality rates associated with a communitywide cardiovascular disease prevention program in Maine.
Although nearly twice as many people in the U.S. were diagnosed with end-stage renal disease in 2012 compared with 20 years ago, the number of new cases diagnosed annually has fallen since 2010
Many older adults with diabetes may be overtreated for their disease, potentially leaving them more susceptible to more serious health threats as a result of adverse effects from medication, a new study warns.
The Food and Drug Administration approved 41 first-of-a-kind drugs in 2014, including a record number of medicines for rare diseases, pushing the agency's annual tally of drug approvals to its highest level in 18 years.
Electronic health-record supplier Cerner Corp. and upstart cloud-based mobile application developer Livongo Health are entering a multiyear partnership to link their systems for diabetes care.